Found 321 matching trials
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309) PHASE3 This multi-center, randomized, double blind, parallel-group, placebo-contro...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders. NA The aim of the present study is to evaluate the effectiveness of the additi...
Show More Learn More & Join Trial
Effect of Ashwagandha as Adjunct Therapy on BDNF and Cognitive Function in Schizophrenia Patients NA This study aims to evaluate the effectiveness of Ashwagandha (Withania somn...
Show More Location
Dadi Psychiatric Hospital (RSJ Dadi) Makassar
Learn More & Join Trial
A RCT Study in Schizophrenia Relapse Prevention NA THE AIM OF THE PROJECT The main aim lies in the prevention of frequent rela...
Show More Location
Prague Psychiatric Center
Learn More & Join Trial
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia PHASE3 The purpose of the study is to evaluate the safety, tolerability and treatm...
Show More Location
Multiple Locations
Learn More & Join Trial
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis PHASE4 SchizOMICS is a Phase IV, multicenter, dose-flexible, open-label, randomize...
Show More Location
Multiple Locations
Learn More & Join Trial
CLinical Utility of Early Intervention Including the 5-Step Precision Medicine (5SPM) Method in First-episode Psychosis: The CLUMP Project N/A CLUMP is a project of translational research that intends to bridge the gap...
Show More Status
Active Not Recruiting
Location
Instituto de Investigación Biomédica de Salamanca (IBSAL)
Learn More & Join Trial
Energy Homeostasis Under Treatment With Atypical Antipsychotics PHASE4 The purpose of this study is to evaluate the effects of different atypical ...
Show More Location
Charité Universitaetsmedizin Berlin; Campus Charité Mitte; Dept. for Psychiatry and Psychotherapy
Learn More & Join Trial
Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone NA Having a diagnosis of schizophrenia or bipolar disorder and being treated w...
Show More Location
The University of Texas Health Science Center At San Antonio
Learn More & Join Trial
Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia NA TD is a troublesome and potentially irreversible side effect associated wit...
Show More Location
Centre for Addiction and Mental Health
Learn More & Join Trial